---
schema_version: "secwatch.filing_event.v1"
accession: "0001801170-24-000182"
form_type: "8-K"
ticker: "CLOV"
cik: "0001801170"
company_name: "CLOVER HEALTH INVESTMENTS, CORP. /DE"
filed_at: "2024-08-22T23:59:59+00:00"
generated_at: "2026-05-31T08:06:34.177356+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Clover Health appoints former Molina Healthcare CFO Thomas L. Tran to Board and Audit Committee

## Summary
- Thomas L. Tran appointed Class II director and Audit Committee member; Board expanded from 8 to 9.
- Tran brings 35+ yrs healthcare finance experience; was CFO of Molina Healthcare (2018-2021) and Upstream Care (2022-2023).
- Tran receives pro-rated annual retainer and $200K RSU award for 2024 service under Clover's director compensation policy.
- Tran entered standard indemnification agreement; no arrangements or family relationships with officers/directors.

## SEC filing metadata
- accession: 0001801170-24-000182
- form_type: 8-K
- ticker: CLOV
- cik: 0001801170
- company_name: CLOVER HEALTH INVESTMENTS, CORP. /DE
- filed_at: 2024-08-22T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1801170/000180117024000182/0001801170-24-000182-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1801170/000180117024000182/clov-20240820.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001801170-24-000182
- JSON: https://secwatch.observer/filing/0001801170-24-000182.json
- Plain text: https://secwatch.observer/filing/0001801170-24-000182.txt

## Key facts
- Executive change
  Thomas L. Tran was appointed as Class II director at CLOVER HEALTH INVESTMENTS, CORP. /DE.
  - Action: appointed
  - Role: Class II director
  source text: On August 20, 2024, the Board of Directors (the "Board") of Clover Health Investments, Corp. ("Clover" or the "Company") appointed Thomas L. Tran, to serve as a Class II director of the Board.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1801170/000180117024000182/0001801170-24-000182-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.